Aviva’s Zynex ZYXI Stock Holding History

Aviva’s Portfolio ZYXI Stock Details ZYXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,272	Closed	-$201K	–	982
2024 Q1	$201K	Sell	16,272 -50,973	-76%	-$612K	﹤0.01%	949
2023 Q4	$732K	Buy	+67,245	New	+$599K	﹤0.01%	722

Other funds holding ZYXI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Aviva's ZYXI Position: Q2 2024 in Review

Aviva sold out of Zynex (ZYXI) in Q2 2024, closing a stake of 16,272 shares — an estimated $201K sold.

Aviva first reported a position in ZYXI in Q4 2023 and held it in 2 quarters. The position peaked at $732K in Q4 2023. 110 funds tracked by Wall St. Rank hold ZYXI as of Q2 2024.

Aviva reported no remaining Zynex position as of Q2 2024 after selling out during the quarter.
Aviva sold 16,272 Zynex shares in Q2 2024, an estimated $201K.
Aviva first reported a position in Zynex in Q4 2023 and held it in 2 quarters.
Aviva's Zynex position peaked at $732K in Q4 2023.
110 funds tracked by Wall St. Rank held Zynex as of Q2 2024.

Based on Aviva's 13F filing for Q2 2024, filed 2 Aug 2024.